SATELLOS BIOSCIENCE

Satellos Bioscience is a regenerative medicine company formed in 2018 as a partnership among Dr. Michael Rudnicki, one of the country’s foremost stem cell scientists and CEO of the Stemcell Network of Canada, Bloom Burton & Co. – the nation’s largest healthcare investment bank -- and Mr. Frank Gleeson, a serial biotech entrepreneur and former healthcare VC. Satellos has recently completed a seed round of financing to pursue its unique approach of pharmacologically modulating stem cell polarity to stimulate in vivo tissue repair and regeneration. Our initial focus is muscle regeneration, a field in which Dr. Rudnicki is a world leader, with a lead program in Duchenne Muscular Dystrophy.